West Pharmaceutical Services Debt to Equity Ratio 2010-2023 | WST

Current and historical debt to equity ratio values for West Pharmaceutical Services (WST) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. West Pharmaceutical Services debt/equity for the three months ending December 31, 2023 was 0.03.
West Pharmaceutical Services Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2023-12-31 $0.95B $2.88B 0.33
2023-09-30 $0.89B $2.87B 0.31
2023-06-30 $0.92B $2.75B 0.34
2023-03-31 $0.95B $2.78B 0.34
2022-12-31 $0.93B $2.69B 0.35
2022-09-30 $0.85B $2.47B 0.34
2022-06-30 $0.94B $2.42B 0.39
2022-03-31 $0.97B $2.33B 0.42
2021-12-31 $0.98B $2.34B 0.42
2021-09-30 $0.94B $2.20B 0.43
2021-06-30 $0.90B $2.03B 0.44
2021-03-31 $0.91B $1.83B 0.50
2020-12-31 $0.94B $1.86B 0.51
2020-09-30 $0.86B $1.72B 0.50
2020-06-30 $0.79B $1.61B 0.49
2020-03-31 $0.76B $1.49B 0.51
2019-12-31 $0.77B $1.57B 0.49
2019-09-30 $0.69B $1.49B 0.46
2019-06-30 $0.68B $1.45B 0.47
2019-03-31 $0.67B $1.37B 0.49
2018-12-31 $0.58B $1.40B 0.42
2018-09-30 $0.59B $1.35B 0.44
2018-06-30 $0.59B $1.28B 0.46
2018-03-31 $0.56B $1.31B 0.43
2017-12-31 $0.58B $1.28B 0.46
2017-09-30 $0.61B $1.32B 0.47
2017-06-30 $0.60B $1.24B 0.48
2017-03-31 $0.57B $1.17B 0.48
2016-12-31 $0.60B $1.12B 0.54
2016-09-30 $0.59B $1.14B 0.52
2016-06-30 $0.60B $1.11B 0.54
2016-03-31 $0.59B $1.07B 0.55
2015-12-31 $0.67B $1.02B 0.66
2015-09-30 $0.67B $1.00B 0.67
2015-06-30 $0.67B $0.99B 0.68
2015-03-31 $0.66B $0.94B 0.70
2014-12-31 $0.71B $0.96B 0.75
2014-09-30 $0.70B $0.97B 0.73
2014-06-30 $0.73B $0.97B 0.75
2014-03-31 $0.77B $0.94B 0.83
2013-12-31 $0.77B $0.91B 0.84
2013-09-30 $0.83B $0.84B 0.99
2013-06-30 $0.83B $0.78B 1.06
2013-03-31 $0.83B $0.75B 1.11
2012-12-31 $0.84B $0.73B 1.15
2012-09-30 $0.81B $0.72B 1.13
2012-06-30 $0.78B $0.68B 1.15
2012-03-31 $0.76B $0.70B 1.10
2011-12-31 $0.74B $0.66B 1.14
2011-09-30 $0.71B $0.69B 1.02
2011-06-30 $0.72B $0.70B 1.03
2011-03-31 $0.70B $0.66B 1.06
2010-12-31 $0.67B $0.63B 1.07
2010-09-30 $0.67B $0.63B 1.06
2010-06-30 $0.65B $0.57B 1.14
2010-03-31 $0.67B $0.58B 1.16
2009-12-31 $0.69B $0.58B 1.20
2009-09-30 $0.70B $0.57B 1.23
2009-06-30 $0.69B $0.53B 1.28
2009-03-31 $0.65B $0.49B 1.34
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $27.235B $2.950B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $68.967B 18.46
Becton Dickinson (BDX) United States $67.638B 19.64
Cardinal Health (CAH) United States $26.315B 15.82
Align Technology (ALGN) United States $22.499B 45.37
Cooper (COO) United States $17.972B 27.19
Labcorp (LH) United States $16.950B 14.47
Henry Schein (HSIC) United States $9.104B 15.75
DENTSPLY SIRONA (XRAY) United States $6.325B 16.67
Merit Medical Systems (MMSI) United States $4.182B 23.93
Patterson (PDCO) United States $2.331B 11.17
STAAR Surgical (STAA) United States $2.267B 71.37
CONMED (CNMD) United States $2.237B 21.06
Atrion (ATRI) United States $0.708B 36.48
Lifevantage (LFVN) United States $0.086B 13.96
Pro-Dex (PDEX) United States $0.067B 25.33
Biolase (BIOL) United States $0.005B 0.00